An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug – Paxlovid – is intended for use soon after symptoms develop in people at high risk of severe disease.
Pfizer says it stopped trials early as the initial results were so positive.
It comes the day after the UK medicines regulator approved a similar treatment from Merck Sharp and Dohme (MSD).
Please subscribe HERE http://bit.ly/1rbfUog
#Covid #BBCNews
Today, Chris Mason is joined by Ailbhe Rea from the New Statesman and Tim Shipman from the Spectator to review…
L'edizione della notte del Tg diretto da Enrico Mentana
Ukrainian president Volodymyr Zelensky has warned that his army will struggle to fight on effectively if a crunch European summit…
L'informazione della testata giornalistica di LA7 diretta da Enrico Mentana
BREAKING NEWS: Thousands of documents from two criminal investigations into the late sex offender Jeffrey Epstein have been released in…
BREAKING NEWS: Thousands of documents from two criminal investigations into the late sex offender Jeffrey Epstein have been released in…